Ameriprise Financial Inc Relay Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 276,452 shares of RLAY stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

276,452

Previous 219,725 25.82%

Holding current value

$1.19 Million

Previous $1.43 Million 36.66%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.23 - $9.51 $353,409 - $539,473	56,727 Added 25.82%	276,452 $1.96 Million
Q2 2024 Aug 14, 2024	SELL	$5.9 - $8.02 $1.36 Million - $1.85 Million	-230,447 Reduced 51.19%	219,725 $1.43 Million
Q1 2024 May 15, 2024	SELL	$7.5 - $12.07 $70,282 - $113,107	-9,371 Reduced 2.04%	450,172 $3.74 Million
Q4 2023 Feb 14, 2024	BUY	$6.01 - $11.48 $2.19 Million - $4.18 Million	364,327 Added 382.63%	459,543 $5.06 Million
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $57,333 - $90,245	6,958 Added 7.88%	95,216 $800,000
Q2 2023 Aug 14, 2023	SELL	$9.99 - $18.27 $161,228 - $294,859	-16,139 Reduced 15.46%	88,258 $1.11 Million
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $298,800 - $453,379	19,920 Added 23.58%	104,397 $1.72 Million
Q4 2022 Feb 14, 2023	SELL	$14.16 - $24.02 $11,412 - $19,360	-806 Reduced 0.95%	84,477 $1.26 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $4,101 - $7,120	227 Added 0.27%	85,283 $1.91 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $159,746 - $418,629	12,002 Added 16.43%	85,056 $1.43 Million
Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $165,240 - $263,928	8,156 Added 12.57%	73,054 $2.19 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $564,798 - $804,402	21,723 Added 50.31%	64,898 $1.99 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $106,624 - $136,156	3,584 Added 9.05%	43,175 $1.36 Million
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $88,137 - $122,398	3,205 Added 8.81%	39,591 $1.45 Million
Q1 2021 May 17, 2021	SELL	$32.52 - $61.53 $257,786 - $487,748	-7,927 Reduced 17.89%	36,386 $1.26 Million
Q4 2020 Feb 12, 2021	SELL	$35.51 - $54.03 $54,401 - $82,773	-1,532 Reduced 3.34%	44,313 $1.84 Million
Q3 2020 Nov 16, 2020	BUY	$32.81 - $45.1 $1.5 Million - $2.07 Million	45,845 New	45,845 $1.95 Million

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $517M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Relay Therapeutics, Inc. Transaction History